OXERVATE (cenegermin-bkbj)
SELF ADMINISTRATION
Indications for Prior Authorization:
- Treatment of neurotrophic keratitis
Patients must meet the following criteria for the indication(s) above:
- Diagnosis of neurotrophic keratitis confirmed by chart note documentation, AND
- Prescribed by or in consultation with an ophthalmologist
Dosing:
- One drop into the affected eye(s) 6 times per day at 2-hour intervals for 8 weeks
Approval:
- 8 weeks
Last review date: September 3, 2019